STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
DelistingMay 8, 2026, 05:07 PM

Rockwell Medical Receives Nasdaq Delisting Notice for Bid Price

AI Summary

Rockwell Medical, Inc. received a notice from Nasdaq on May 8, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company's common stock traded below $1.00 for 30 consecutive business days. Rockwell Medical has 180 calendar days, until November 4, 2026, to regain compliance. The company plans to propose a reverse stock split to its stockholders to address this issue.

Key Highlights

  • Rockwell Medical received a Nasdaq notice on May 8, 2026, for non-compliance with the $1.00 minimum bid price rule.
  • The company's common stock traded below $1.00 for 30 consecutive business days.
  • Rockwell Medical has 180 calendar days, until November 4, 2026, to regain compliance.
  • To regain compliance, the stock must close at or above $1.00 for at least ten consecutive business days.
  • The company plans to propose a reverse stock split to stockholders to meet listing requirements.
RMTI
Biotechnology: Pharmaceutical Preparations
ROCKWELL MEDICAL, INC.

Price Impact